ARCHIVES

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

This article is from The Cancer Letter archive.

Vol. 07 No. 21 | May 22, 1981

Download PDF Visit The Full Archive

Related Articles

Only 20% of Doctors Advise CRC According To Guidelines

October 29, 2010

Senate Subcommittee Approves 3.5 Percent Increase for NIH.

June 29, 2007

NCI to Fund 122 More Grants in FY04

March 28, 2003

Broder Encourages Support Of Drug Development Programs

March 10, 1995

Seattle Cancer Care Alliance Outpatient Clinic to Open – Jan. 19, 2001

June 7, 2021

Three Nurse Awards Made In Self Care

September 30, 1988